Vaso Corporation Announces Extension of Exclusive Sales Representation Agreement with GE Healthcare Through 2022   Plainview, NY, December 4, 2017 – Vaso Corporation (OTC PK: VASO) (formerly Vasomedical, Inc.) today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE Healthcare (“GEHC”), the healthcare business unit of...
Read More

Plainview, NY, November 14, 2017 – Vaso Corporation (OTC PK: VASO) (formerly Vasomedical, Inc.) today reported its operating results for the three months ended September 30, 2017. “We are pleased to report that the Company achieved continued revenue growth to $18.0 million for the third quarter of 2017, thanks to the double digit year-over-year growth...
Read More

 PLAINVIEW, N.Y. August 14, 2017 – Vaso Corporation (“Vaso”) (OTCMKTS: VASO) today reported its operating results for the three months ended June 30, 2017. “In the second quarter of 2017 we recorded a total revenue of $17.9 million, of which our IT, professional sales service and equipment segments contributed 60%, 34% and 6%, respectively. Revenue...
Read More

VasoHealthcareIT Wins Terasaki Medical Innovation Award Innovative Cloud Imaging Solutions Speeds Up Donor Match Turnaround Times (Nashville, TN – May 23, 2017) VasoHealthcareIT (VHCIT), a wholly owned subsidiary of Vaso Corporation (VASO) (OTCMKTS: VASO), today proudly announces the winning of the prestigious Terasaki Medical Innovation Award by the National Kidney Registry (NKR).   In its...
Read More

PLAINVIEW, N.Y. May 15, 2017 – Vaso Corporation (“Vaso”) (OTCMKTS: VASO) today reported its operating results for the three months ended March 31, 2017. “Our revenue decreased by $1.2 million, or 7%, in the first quarter of 2017 when compared to the first quarter of the prior year, principally due to a decrease in revenue...
Read More